Welcome to our dedicated page for Lifevantage Corporation news (Ticker: $LFVN), a resource for investors and traders seeking the latest updates and insights on Lifevantage Corporation stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Lifevantage Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Lifevantage Corporation's position in the market.
LifeVantage (LFVN) will participate in the Sidoti Micro Cap Conference on May 8-9, 2024. The President, CEO, and CFO will present to investors. The webcast will be available on the company's Investor Relations website.
LifeVantage (Nasdaq:LFVN) declared a quarterly cash dividend of $0.04 per share, reflecting a 14.3% increase from the previous quarter. The dividend will be paid on June 14, 2024, to stockholders of record as of May 31, 2024.
LifeVantage reported financial results for the third quarter of Fiscal 2024 with revenue of $48.2 million, a 10.2% decrease from the prior year. Adjusted EBITDA increased by 54.7% to $5.1 million. Despite revenue declines in the Americas and Asia/Pacific & Europe, positive trends were seen in operating margins and productivity gains. The company repurchased shares and announced a cash dividend of $0.04 per share. Fiscal Year 2024 guidance projects revenue of $202-$205 million and adjusted EBITDA of $16-$18 million.